Metacrine Inc (MTCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MTCR | AMGN | VRTX | REGN | BMY |
| Company | Metacrine Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.5883 | 314.11 | 446.00 | 987.99 | 43.14 |
| High | 0.5905 | 316.67 | 446.00 | 991.00 | 43.41 |
| Low | 0.5800 | 311.90 | 443.37 | 983.09 | 43.06 |
| Last | 0.5814 | 315.11 | 445.38 | 991.89 | 43.06 |
| Change | -0.0076 | +0.57 | -0.49 | +4.62 | -0.30 |
| % Change | -1.29% | +0.18% | -0.11% | +0.47% | -0.69% |
| Volume | 83,800 | 126,933 | 47,454 | 20,837 | 1,063,511 |
| 20-Day Average Volume | 57,870 | 2,754,092 | 1,038,658 | 438,122 | 14,688,886 |
| Previous Close | 0.5890 | 314.54 | 445.87 | 987.27 | 43.36 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5659 | 297.81 | 416.74 | 947.77 | 44.45 |
| 20-Day Raw Stochastic | 88.35% | 87.82% | 95.79% | 99.40% | 0.33% |
| 20-Day Relative Strength | 55.86% | 65.14% | 71.95% | 62.87% | 30.54% |
| Weighted Alpha | +30.95 | +43.11 | +35.97 | +36.05 | -34.49 |
| Today's Opinion | 100% Buy | 72% Buy | 72% Buy | 88% Buy | 100% Sell |
| Previous Opinion | 100% Buy | 72% Buy | 72% Buy | 100% Buy | 100% Sell |
| Last Month's Opinion | 88% Buy | 40% Sell | 8% Buy | 24% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.00% since 06/12/23 | +1.37% since 05/14/24 | +3.94% since 05/14/24 | +0.57% since 05/14/24 | -3.66% since 05/14/24 |
| Low | 0.5502 on 06/13/23 | 310.37 on 05/17/24 | 428.62 on 05/15/24 | 966.00 on 05/17/24 | 43.06 on 05/21/24 |
| High | 0.5905 on 06/20/23 | 321.44 on 05/15/24 | 447.85 on 05/20/24 | 991.00 on 05/21/24 | 45.17 on 05/15/24 |
| 1-Month | |||||
| %Chg | +2.43% since 05/19/23 | +17.38% since 04/19/24 | +12.99% since 04/19/24 | +10.42% since 04/19/24 | -11.97% since 04/19/24 |
| Low | 0.5124 on 05/30/23 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 43.06 on 05/21/24 |
| High | 0.5905 on 06/20/23 | 322.60 on 05/03/24 | 447.85 on 05/20/24 | 991.00 on 05/21/24 | 49.56 on 04/22/24 |
| 3-Month | |||||
| %Chg | +2.41% since 03/20/23 | +11.36% since 02/21/24 | +6.16% since 02/21/24 | +3.93% since 02/21/24 | -15.39% since 02/21/24 |
| Low | 0.5124 on 05/30/23 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.06 on 05/21/24 |
| High | 0.5905 on 06/20/23 | 322.60 on 05/03/24 | 447.85 on 05/20/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +39.42% since 12/20/22 | +20.11% since 11/21/23 | +25.57% since 11/21/23 | +23.97% since 11/21/23 | -11.15% since 11/21/23 |
| Low | 0.3905 on 12/21/22 | 260.68 on 04/19/24 | 346.29 on 11/28/23 | 792.57 on 11/28/23 | 43.06 on 05/21/24 |
| High | 0.5905 on 06/20/23 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 24,750 | 168,730,256 | 115,058,088 | 108,783,320 | 87,895,056 |
| Shares Outstanding, K | 42,570 | 536,435 | 258,053 | 110,186 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -62,210,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 11,865,000,000 |
| Last Quarter Net Income | -5,520,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -11,911,000,000 |
| 60-Month Beta | -0.73 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.13 on 11/14/22 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 06/22/23 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.77 | 29.56 | 26.47 | 41.93 |